Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

NACompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Diabetes Mellitus, Type 2
Interventions
DEVICE

Bolus Insulin Patch (Calibra Finesse)

DEVICE

Insulin Pen (Novo-Nordisk FlexPen®)

Trial Locations (52)

13210

SUNY Upstate Medical University, Syracuse

20782

Medstar Health Research Institute, Hyattsville

24541

Danville Internal Medicine, Danville

30046

Physicians Research Associates, Lawrenceville

30076

Endocrine Research Solutions, Inc, Roswell

30318

Atlanta Diabetes Associates, Atlanta

31904

Columbus Regional Research Institute, Columbus

33000

Hopital Saint-Andre, Bordeaux

34295

Lapeyronie Hospital, University Hospital Montpellier, Montpellier

36037

BAG Unterm Heilig Kreuz Unterm Heilig Kreuz, Fulda

37411

University Diabetes and Endocrine Consultants, Chattanooga

40503

Kentucky Diabetes Endocrinology Center, Lexington

44093

CHU de Nantes-Hospital Nord Laennec, Saint-Herblain

44106

VA Medical Center Cleveland, Cleveland

44137

Diabeteszentrum DO-Diabetologisch, Dortmund

48202

Henry Ford Health System, Detroit

50314

Iowa Diabetes and Endocrinology Research Center, Des Moines

55116

Diabetes Zentrum und Praxis Prof. Pfutzner Parcusstr., Mainz

55416

Park Nicollet Institute International Diabetes Center, Minneapolis

60611

Northwestern University The Feinberg School of Medicine, Chicago

60612

John H. Stroger, Jr. Hospital of Cook County Diabetes Center, Chicago

66606

Cotton-O'Neil Clinical Research Center, Topeka

67212

Great Plains Diabetes, Wichita

69200

GHMP les Portes du Sud, Vénissieux

71200

Hopital Hotel-Dieu Site Harfleur, Le Creusot

75230

Dallas Diabetes and Endocrine Center, Dallas

75246

Baylor Endocrine Center, Dallas

75475

Hopital Lariboisiere, Centre Universitaire du Diabete et de ses Complications, Paris

78229

Diabetes & Glandular Disease Clinic, P.A., San Antonio

South Texas Veterans Health Care System, San Antonio

78258

Consano Clinical Research, San Antonio

78749

Texas Diabetes & Endocrinology, P.A.- Austin, Austin

80220

Denver VA Medical Center, Denver

83404

Rocky Mountain Diabetes and Osteoporosis Center PA, Idaho Falls

84010

Progressive Clinical Research, Bountiful

84124

Highland Clinical Research, Salt Lake City

85020

Central Phoenix Medical Clinic, Phoenix

90057

National Research Institute - Wilshire, Los Angeles

91978

Encompass Clinical Research, Spring Valley

92025

Advanced Metabolic Care & Research Institute, Inc. (AMCR), Escondido

93009

Hopital Avicenne, Bobigny

94401

Diabetes Research Institute Mills-Peninsula Health Service, San Mateo

94904

Marin Endocrine Care and Research, Greenbrae

98003

Private Practice-Larry Stonesifer, Federal Way

98057

Rainier Clinical Research Center, Renton

BA1 3NG

Royal United Hospital, Diabetes & Lipid Research Wolfson Centre, Bath

BB2 3HH

Royal Blackburn Hospital, East Lancashire Hospitals NHS Trust, Blackburn

PR7 1PP

Chorley and South Ribble Hospital, Chorley

DD1 9SY

Ninewells Hospital & Medical School Diabetes Support Unit, Dundee

FK5 4WR

Forth Valley Royal Hospital Dept. of Diabetes, Larbert

LE5 4PW

Leicester General Hospital Leicester Diabetes Centre, Leicester

L7 8XP

Royal Liverpool University Hospital, Liverpool

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medpace, Inc.

INDUSTRY

lead

Calibra Medical, Inc.

INDUSTRY